Chemistry - A European Journal
10.1002/chem.201801253
COMMUNICATION
cytoplasmic thiols (such as CoA or glutathione) would rapidly
convert 1 to the major species 2, which predominantly exists as
the thiolate in cells under physiological conditions (pH 7.4). While
non-enzymatic hydrolysis is likely negligible, the slower direct
acyl-transfer to proteinogenic amines may be a viable, albeit
minor, pathway. Although 1 may be regenerated from 2 via acetyl-
CoA,[8] the formation of 1 is strongly disfavored at equilibrium, as
demonstrated by the reaction of 1 with 3.
In summary, a detailed investigation of SAMT kinetics and
molecular properties has provided insight into both productive and
unproductive SAMT reaction pathways in cells. The
predominance of thiol–thioester exchange (as compared to other
nucelophiles), the high equilibrium abundance of the thiolate 2 (as
compared to the more reactive metabolites 1, 6, and 10), and the
application of interconnected acetylative and oxidative reaction
manifolds to the mechanism of HIV inactivation, are particularly
notable. Moreover, it led to a three-step synthesis of SAMT-247
(
1), which was conducted on 75 mmol scale with 64% overall yield,
Table 1. Antiviral activity [EC50 (µM)], toxicity [TC50 (µM)], and therapeutic
index (TI) of SAMT-247 (1).
utilizes inexpensive reagents ($4/mmol), and avoids any
chromatography.
Compound
EC50 (µM)
1.3 ± 0.7
0.9 ± 0.3
TC50 (µM)
>100
TC50/EC50 (TI)
>77
1
+ 1% EtOH
Acknowledgements
1
>100
>100
This research was supported by the Intramural Research
Program of NIDDK, NIH. We thank Tracy L. Hartman and Robert
W. Buckheit, Jr. of ImQuest Biosciences (Frederick, MD) for
performing antiviral assays, John Lloyd for performing mass
spectrometry, and Robert O’Connor for assistance with NMR. The
X-ray crystallographic work was supported by NIDA through
Interagency Agreement (IAA) ADA17001 with the Naval
Research Laboratory (NRL).
Alternatively, in the presence of H
2
O
2
, O
2
, or other reactive
oxygen species (ROS) in cells, 2 may be oxidized to a mixed
disulfide (10). From our experience in synthesizing 6, we propose
that direct oxidation from 2 to the benzisothiazolinone 6 is unlikely.
Although 10 may disproportionate to 6 in vitro, the high reactivity
of both 6 and 10 towards thiol nucleophiles, as demonstrated by
the mercaptobenzamide–catalyzed oxidation of N-acetyl-L-
cysteine (S6), suggests that the equilibrium concentration of 10,
and particularly 6, is also low.
Keywords: HIV • nucleocapsid • mercaptobenzamide • scalable
synthesis • antiviral mechanism • reaction kinetics
Nevertheless, fast acetylative and oxidative reaction
kinetics, in combination with the capacity of 1, 6, and 10 to
regenerate from the thiolate 2, suggest that loss of HIV infectivity
via 1–mediated NCp7 denaturation, followed by 6– or 10–
catalyzed Gag crosslinking, is a viable mechanism of action for
this class of antivirals. Moreover, low equilibrium concentrations
of active metabolites (1, 6, and 10) may explain the low toxicity
and micromolar activity of the SAMTs.
[
1] A list of currently approved inhibitors can be found on the U.S. Food and
Drug Administration website, titled: Antiretroviral drugs used in the
/treatment/ucm118915.htm. Page last updated: 8/9/16.
[2] Estimate from "Global AIDS Update 2016," prepared by Joint United
sites/default/files/media_asset/global-AIDS-update-2016_en.pdf.
accessed: 11/28/17.
Last
[3] K. A. Gebo, J. A. Fleishman, R. Conviser, J. Hellinger, F. J. Hellinger, J.
S. Josephs, P. Keiser, P. Gaist, R. D. Moore, AIDS (London, England)
2010, 24, 2705-2715.
[
[
4] D. A. Solomon, P. E. Sax, Curr. Opin. HIV AIDS 2015, 10, 219-225.
5] a) L. Sancineto, N. Iraci, O. Tabarrini, C. Santi, Drug Discovery Today
2017; b) D. Garg, B. E. Torbett, Virus Res. 2014, 193, 135-143; c) H. de
Rocquigny, V. Shvadchak, S. Avilov, C. Z. Dong, U. Dietrich, J. L. Darlix,
Y. Mely, Mini Rev. Med. Chem. 2008, 8, 24-35; d) V. Goldschmidt, L. M.
Miller Jenkins, H. de Rocquigny, J.-L. Darlix, Y. Mély, HIV Ther. 2010, 4,
179-198.
[
6] a) J. L. Darlix, J. L. Garrido, N. Morellet, Y. Mély, H. d. Rocquigny,
Properties, Functions, and Drug Targeting of the Multifunctional
Nucleocapsid Protein of the Human Immunodeficiency Virus. In Adv.
Pharmacol., Academic Press2007; Vol. 55, pp 299-346; b) J. A. Thomas,
R. J. Gorelick, Virus Res. 2008, 134, 39-63.
[
7] a) L. M. Miller Jenkins, J. C. Byrd, T. Hara, P. Srivastava, S. J. Mazur, S.
J. Stahl, J. K. Inman, E. Appella, J. G. Omichinski, P. Legault, J. Med.
Chem. 2005, 48, 2847-2858; b) P. Srivastava, M. Schito, R. J. Fattah, T.
Hara, T. Hartman, R. W. Buckheit, J. A. Turpin, J. K. Inman, E. Appella,
Biorg. Med. Chem. 2004, 12, 6437-6450.
[8] L. M. M. Jenkins, D. E. Ott, R. Hayashi, L. V. Coren, D. Wang, Q. Xu, M.
L. Schito, J. K. Inman, D. H. Appella, E. Appella, Nat. Chem. Biol. 2010,
6, 887-889.
[9] a) M. L. Schito, A. Goel, Y. Song, J. K. Inman, R. J. Fattah, W. G. Rice, J.
A. Turpin, A. Sher, E. Appella, AIDS Res. Hum. Retroviruses 2003, 19,
9
1-101; b) M. L. Schito, A. C. Soloff, D. Slovitz, A. Trichel, J. K. Inman, E.
Appella, J. A. Turpin, S. M. Barratt-Boyes, Curr. HIV Res. 2006, 4, 379-
86.
3
[10] a) G. S. Wallace, C. Cheng-Mayer, M. L. Schito, P. Fletcher, L. M. Miller
Scheme 3. Proposed acetylative and oxidative mechanistic cycles for in vivo
SAMT-247 (1)–induced HIV inactivation via NCp7 denaturation and formation
of Gag crosslinks.
Jenkins, R. Hayashi, A. R. Neurath, E. Appella, R. J. Shattock, J. Virol.
2009, 83, 9175-9182; b) S. R. Ugaonkar, J. T. Clark, L. B. English, T. J.
Johnson, K. W. Buckheit, R. J. Bahde, D. H. Appella, R. W. Buckheit, P.
F. Kiser, J. Pharm. Sci. 2015, 104, 3426-3439; c) Y. Yang, J. Zhu, M.
This article is protected by copyright. All rights reserved.